ERBB signaling attenuates proinflammatory activation of nonclassical monocytes

Immune activation in chronic systolic heart failure (HF) correlates with disease severity and prognosis. Recombinant neuregulin-1 (rNRG-1) is being developed as a possible therapy for HF, based on the activation of ERBB receptors in cardiac cells. Work in animal models of HF led us to hypothesize th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Physiol Heart Circ Physiol
Päätekijät: Ryzhov, Sergey, Matafonov, Anton, Galindo, Cristi L., Zhang, Qinkun, Tran, Truc-Linh, Lenihan, Daniel J., Lenneman, Carrie Geisberg, Feoktistov, Igor, Sawyer, Douglas B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Physiological Society 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5451588/
https://ncbi.nlm.nih.gov/pubmed/28235789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00486.2016
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia